New study aims to close the gap in HIV prevention for women and trans people
NCT ID NCT05165745
Summary
This study aims to understand how to better help cisgender women and transgender individuals start and stay on daily medication that prevents HIV (called PrEP). Researchers will survey about 175 participants to learn their preferences for different prevention methods and support tools, like text reminders. The goal is to find the most effective ways to support people at risk of HIV in using prevention care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.